Stock Events

Stock Events

Monopar Therapeutics (MNPR) Q3 2026 Earnings

6AugConfirmed

Q3 2025

Q4 2025

Q2 2026

Next

-0.67

-0.57

-0.46

-0.35

Details

Expected EPS

-0.600615

Actual EPS

N/A

Surprise EPS

0.6

Surprise Percent

+100%

Description

Monopar Therapeutics (MNPR) will report earnings of for Q3 2026 on August 06, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.